Legal Representation
Attorney
Alyssa Worsham
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20191224)
Due Date
December 24, 2025
Grace Period Ends
June 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 11, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Dec 24, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 4, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Dec 24, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 21, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 20, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 28, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 23, 2019 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 28, 2019 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Oct 23, 2019 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Oct 25, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 23, 2019 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Oct 23, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 3, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 2, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 5, 2019 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 2, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 15, 2019 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Aug 15, 2019 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Aug 15, 2019 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Aug 15, 2019 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Feb 5, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 11, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 11, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 21, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 2, 2018 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 2, 2018 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 18, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 15, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 14, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 14, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 31, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Aug 31, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Aug 31, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Aug 30, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 18, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 12, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
reagents and instruments for scientific, research or non-medical or veterinary diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for scientific or research use in the fields of cancer, neurology and infectious disease; reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for scientific, research or non-medical or veterinary diagnostic use containing antibodies and nucleic acids; reagent kits comprising primarily reagents for scientific, research or non-medical or veterinary diagnostic use in the fields of cancer, neurology and infectious disease; reagents for immuno-histochemistry detection and in situ-hybridization detection for scientific, research or non-medical or veterinary diagnostic use; test kits for scientific, research or non-medical or veterinary diagnostic use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor; test kits comprising reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification; reagents for in vitro use in clinical chemistry and molecular biology; reagents for clinical or medical laboratory use, namely, reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling, nucleic acid sequencing, and clinical, oncology, neurology, and infectious disease diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers
First Use Anywhere:
Sep 3, 2019
First Use in Commerce:
Sep 3, 2019
Class 009
automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for detection and analysis of biomolecules for scientific use; automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for scientific research, namely, for detecting, collecting and processing optical signals and images, into data for use in the analysis of biomolecules in connection with scientific or medical research; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics and computer systems for digitizing images of biological tissue for use in connection with pathology; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics and computer systems for capturing digital images of microscope slides of biological tissue, storage of digitized microscope slide images in a data storage area, and display of digitized microscope slide images; automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems comprised of computer hardware and software for detection and analysis of, pathology, gene expression, RNA transcription, RNA translation and nucleic acid sequencing; computer hardware and software to enable pathologists to diagnose disease; computer hardware and software for the electronic scanning of clinical pathology slides; computer hardware and software for pathologists to render and report diagnoses and results of scientific research; computer hardware and software for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription and microRNA expression profiling and nucleic acid sequencing; computer hardware and software for digitizing, processing and storing images of biological tissues and cells; computer hardware and software for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining and visualization apparatus; computer hardware and software for identifying and diagnosing cancer and other diseases and processing digital images; computer hardware and software for viewing, analyzing, managing, reporting, and archiving digital images; laboratory equipment for sample preparation, mixing, hybridization, incubation, washing, location and imaging, namely, robotic equipment, fluid mixers, pumps, valves, and containers, reagent holders, sample containers and microfluidic devices, optical devices, scanning microscopes, fluorescent microscopes, digital micromirror devices, electromagnetic sensors and replacement parts therefor in the fields of scientific research; computer systems, namely, software and data files to acquire, analyze, manage and report biological information
First Use Anywhere:
Sep 3, 2019
First Use in Commerce:
Sep 3, 2019
Class 010
clinical and medical diagnostic instruments, namely, histopathology instruments and nucleic acid sequencers; clinical and medical diagnostic instruments for analysis of tissue and/or cell based samples, all for medical purposes; clinical and medical diagnostic instruments for performing immunohistochemistry and in situ-hybridization staining reactions, histological and pathological staining and image processing and analysis; histopathology instruments for clinical purposes; clinical and medical diagnostic instruments for immunohistochemistry and in situ-hybridization analyses; clinical and medical diagnostic instruments for the electronic scanning of clinical pathology slides, processing and storing images of biological tissues and cells and digitizing, processing and storing images of biological tissues and cells
First Use Anywhere:
Sep 3, 2019
First Use in Commerce:
Sep 3, 2019
Class 042
research and product development services for others in the field of biotechnology; medical and scientific research services for others in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research services for others in the field of infectious disease; medical and scientific research services for others in the field of neurology; medical and scientific research services for others, namely, research and design in the field of testing, analyzing and examining biological samples, medical samples, and cell samples; providing laboratory research services for others in the field of gene expression and genetic data mining; research and development services for others for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment; research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes
First Use Anywhere:
Apr 1, 2019
First Use in Commerce:
Apr 1, 2019
Classification
International Classes
001
009
010
042